These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 38434979

  • 1. Analysis of m6A-related lncRNAs for prognostic and immunotherapeutic response in hepatocellular carcinoma.
    Wu X, Wang S, Wu X, Chen Q, Cheng J, Qi Z.
    J Cancer; 2024; 15(7):2045-2065. PubMed ID: 38434979
    [Abstract] [Full Text] [Related]

  • 2. A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma.
    Wang S, Bai H, Fei S, Miao B.
    Biochem Genet; 2024 Jun; 62(3):2332-2351. PubMed ID: 37898914
    [Abstract] [Full Text] [Related]

  • 3. Systematic analysis of the role of LDHs subtype in pan-cancer demonstrates the importance of LDHD in the prognosis of hepatocellular carcinoma patients.
    Wang S, Wu X, Wu X, Cheng J, Chen Q, Qi Z.
    BMC Cancer; 2024 Jan 31; 24(1):156. PubMed ID: 38291366
    [Abstract] [Full Text] [Related]

  • 4. Prediction of prognosis, immune infiltration, and personalized treatment of hepatocellular carcinoma by analysis of cuproptosis-related long noncoding RNAs and verification in vitro.
    Li S, Zhu Z, Lu J, Cao W, Song F, Xiao C, Zhang P, He Z, Weng J, Xu J.
    Front Oncol; 2023 Jan 31; 13():1159126. PubMed ID: 37746284
    [Abstract] [Full Text] [Related]

  • 5. Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma.
    Li W, Chen QF, Huang T, Wu P, Shen L, Huang ZL.
    Front Oncol; 2020 Jan 31; 10():780. PubMed ID: 32587825
    [Abstract] [Full Text] [Related]

  • 6. Analysis of m6A-Related lncRNAs for Prognosis Value and Response to Immune Checkpoint Inhibitors Therapy in Hepatocellular Carcinoma.
    Wang Y, Li N, Tian D, Zhou CW, Wang YH, Yang C, Zeng MS.
    Cancer Manag Res; 2021 Jan 31; 13():6451-6471. PubMed ID: 34429653
    [Abstract] [Full Text] [Related]

  • 7. Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma.
    Huang EM, Ma N, Ma T, Zhou JY, Yang WS, Liu CX, Hou ZH, Chen S, Zong Z, Zeng B, Li YR, Zhou TC.
    World J Gastrointest Oncol; 2022 Oct 15; 14(10):1981-2003. PubMed ID: 36310708
    [Abstract] [Full Text] [Related]

  • 8. Construction of a Necroptosis-Associated Long Non-Coding RNA Signature to Predict Prognosis and Immune Response in Hepatocellular Carcinoma.
    Wang W, Ye Y, Zhang X, Ye X, Liu C, Bao L.
    Front Mol Biosci; 2022 Oct 15; 9():937979. PubMed ID: 35911976
    [Abstract] [Full Text] [Related]

  • 9. Use of 6 m6A-relevant lncRNA genes as prognostic markers of primary liver hepatocellular carcinoma based on TCGA database.
    Zhu XL, Li Q, Shen J, Shan L, Zuo ED, Cheng X.
    Transl Cancer Res; 2021 Dec 15; 10(12):5337-5351. PubMed ID: 35116381
    [Abstract] [Full Text] [Related]

  • 10. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX, Zhang X, Miao RC, Xiang XH, Fu YN, Zhang JY, Liu C, Qu K.
    World J Gastroenterol; 2019 Jan 14; 25(2):220-232. PubMed ID: 30670911
    [Abstract] [Full Text] [Related]

  • 11. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y, Zhu GQ, Tian D, Zhou CW, Li N, Feng Y, Zeng MS.
    BMC Cancer; 2022 Mar 24; 22(1):316. PubMed ID: 35331183
    [Abstract] [Full Text] [Related]

  • 12. Identification of a cuproptosis and copper metabolism gene-related lncRNAs prognostic signature associated with clinical and immunological characteristics of hepatocellular carcinoma.
    Yuan W, Xiao JH, Zhang JS, Mao BL, Wang PZ, Wang BL.
    Front Oncol; 2023 Mar 24; 13():1153353. PubMed ID: 37056336
    [Abstract] [Full Text] [Related]

  • 13. Prognostic Value of N6-Methyladenosine-Related lncRNAs in Early-Stage Colorectal Cancer: Association With Immune Cell Infiltration and Chemotherapeutic Drug Sensitivity.
    Xiong Z, Li X, Yin S, Xie M, Mao C, Zhang F, Chen H, Jin L, Lian L.
    Front Mol Biosci; 2021 Mar 24; 8():724889. PubMed ID: 34712696
    [Abstract] [Full Text] [Related]

  • 14. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ, Zhang J, Xu L, Liu FF.
    World J Gastroenterol; 2018 Aug 14; 24(30):3426-3439. PubMed ID: 30122881
    [Abstract] [Full Text] [Related]

  • 15. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
    Xu Z, Peng B, Liang Q, Chen X, Cai Y, Zeng S, Gao K, Wang X, Yi Q, Gong Z, Yan Y.
    Front Immunol; 2021 Aug 14; 12():719175. PubMed ID: 34603293
    [Abstract] [Full Text] [Related]

  • 16. An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma.
    Chen X, Sun M, Feng W, Chen J, Ji X, Xie M, Huang W, Chen X, Zhang B, Nie Y, Fan D, Wu K, Xia L.
    Front Genet; 2023 Aug 14; 14():1056000. PubMed ID: 36845390
    [Abstract] [Full Text] [Related]

  • 17. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
    Song W, Ren J, Yuan W, Xiang R, Ge Y, Fu T.
    Genes (Basel); 2021 Aug 31; 12(9):. PubMed ID: 34573357
    [Abstract] [Full Text] [Related]

  • 18. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.
    Zhao J, Lin X, Zhuang J, He F.
    Front Genet; 2021 Aug 31; 12():714697. PubMed ID: 34777460
    [Abstract] [Full Text] [Related]

  • 19. Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental validation.
    Wang T, Zhou Z, Wang X, You L, Li W, Zheng C, Zhang J, Wang L, Kong X, Gao Y, Sun X.
    Front Genet; 2022 Aug 31; 13():929035. PubMed ID: 36081998
    [Abstract] [Full Text] [Related]

  • 20. Comprehensive analysis of m5C-Related lncRNAs in the prognosis and immune landscape of hepatocellular carcinoma.
    Lu Q, Liu L, Wang S, Zhang Q, Li L.
    Front Genet; 2022 Aug 31; 13():990594. PubMed ID: 36339006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.